PTH1R (parathyroid hormone 1 receptor) SIGNALING FOR HEIGHT GROWTH (high effort) ABSLOPARATIDE

L1G7

L1G7

Bronze
Joined
Dec 15, 2025
Posts
273
Reputation
281
NEW .ORG ACCOUNT I HAVE BEEN ON FORUMS FOR 7 YEARS
V (MY TIKTOK ACCOUNT) V
:love:WOULD LOVE A FOLLOW IF YOU LIKED THIS POST:love:

1787017728062

ABALOPARATIDE
1787018615667

Absorption:
Abaloparatide is injected and enters the bloodstream
Main pathway:
Activates PTH1R signaling which recruits more osteoblasts
existing osteoblasts STAY alive longer and activates previously inactive bone forming surfaces.


[U][I]PTH1R activation > [/I][/U]
[U][I]LOWER osteoblast apoptosis + INCREASED osteoblast recruitment > [/I][/U]
[U][I]INCREASED active mineralizing surfaces >[/I][/U]
INCREASED bone formation rate

Osteoblast effect:
PTH1R signaling increases osteoblast recruitment More osteoblasts become active and deposit osteoid increasing the amount of bone surface undergoing mineralization.
Bone matrix production:
Active osteoblasts deposit type-I collagen and other proteins forming new osteoid.
on the outside surface of cortical bone.
This is the actual material that increases outward bone volume.

Mineralization:
Calcium and phosphate are then deposited into that newly produced matrix converting the soft osteoid into hard mineralized cortical bone.
Chondrocyte effect:
Delayed maturation:
PTH1R signaling keeps those cells in the proliferative state longer and delays their transition into hypertrophic chondrocytes.
Maintained proliferative pool:
This preserves more immature chondrocytes that can continue dividing before they eventually mature.
12.9× increase:
increased periosteal mineralizing surface from 1.3% to 16.3% after 3 months a 12.9× increase in the amount of periosteal surface actively forming bone
studied osteoporotic population HARD
TO COMPARE % TO NON osteoporotic PEOPLE
https://pubmed.ncbi.nlm.nih.gov/33434314/

INCREASED final height and long bone length
(SOURCES)

t.https://pubmed.ncbi.nlm.nih.gov/26562265/
^ Abaloparatide activates PTH1R ^
https://pubmed.ncbi.nlm.nih.gov/17517365/
^ PTH increases osteoblast survival ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Activates bone forming surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases mineralizing surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases bone formation rate ^
https://pubmed.ncbi.nlm.nih.gov/39349089/
^ Chondrocytes drive bone lengthening ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases periosteal bone formation ^
https://pubmed.ncbi.nlm.nih.gov/31051317/
^ Increases periosteal mineralizing surface ^
https://pubmed.ncbi.nlm.nih.gov/16831900/
^ Delays chondrocyte differentiation ^
https://pubmed.ncbi.nlm.nih.gov/17328886/
^ Regulates chondrocyte proliferation ^
https://pubmed.ncbi.nlm.nih.gov/10571683/
^ Maintains proliferative chondrocytes ^
https://pubmed.ncbi.nlm.nih.gov/25196529/

[SIZE=15px] ^ PTH1R supports long bone growth ^[/SIZE]
[SIZE=26px][B]LMK IF YALL WANT AN UPDATED POST WITH DOSING SOURCING AND SIDE EFFECTS/SIDE EFFECT MITIGATION[/B][/SIZE]
 
NEW .ORG ACCOUNT I HAVE BEEN ON FORUMS FOR 7 YEARS
V (MY TIKTOK ACCOUNT) V
:love:WOULD LOVE A FOLLOW IF YOU LIKED THIS POST:love:

View attachment 5530125
ABALOPARATIDE
View attachment 5530171

Absorption:
Abaloparatide is injected and enters the bloodstream
Main pathway:
Activates PTH1R signaling which recruits more osteoblasts
existing osteoblasts STAY alive longer and activates previously inactive bone forming surfaces.


[U][I]PTH1R activation > [/I][/U]
[U][I]LOWER osteoblast apoptosis + INCREASED osteoblast recruitment > [/I][/U]
[U][I]INCREASED active mineralizing surfaces >[/I][/U]
INCREASED bone formation rate

Osteoblast effect:
PTH1R signaling increases osteoblast recruitment More osteoblasts become active and deposit osteoid increasing the amount of bone surface undergoing mineralization.
Bone matrix production:
Active osteoblasts deposit type-I collagen and other proteins forming new osteoid.
on the outside surface of cortical bone.
This is the actual material that increases outward bone volume.

Mineralization:
Calcium and phosphate are then deposited into that newly produced matrix converting the soft osteoid into hard mineralized cortical bone.
Chondrocyte effect:
Delayed maturation:
PTH1R signaling keeps those cells in the proliferative state longer and delays their transition into hypertrophic chondrocytes.
Maintained proliferative pool:
This preserves more immature chondrocytes that can continue dividing before they eventually mature.
12.9× increase:
increased periosteal mineralizing surface from 1.3% to 16.3% after 3 months a 12.9× increase in the amount of periosteal surface actively forming bone
studied osteoporotic population HARD
TO COMPARE % TO NON osteoporotic PEOPLE
https://pubmed.ncbi.nlm.nih.gov/33434314/

INCREASED final height and long bone length
(SOURCES)

t.https://pubmed.ncbi.nlm.nih.gov/26562265/
^ Abaloparatide activates PTH1R ^
https://pubmed.ncbi.nlm.nih.gov/17517365/
^ PTH increases osteoblast survival ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Activates bone forming surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases mineralizing surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases bone formation rate ^
https://pubmed.ncbi.nlm.nih.gov/39349089/
^ Chondrocytes drive bone lengthening ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases periosteal bone formation ^
https://pubmed.ncbi.nlm.nih.gov/31051317/
^ Increases periosteal mineralizing surface ^
https://pubmed.ncbi.nlm.nih.gov/16831900/
^ Delays chondrocyte differentiation ^
https://pubmed.ncbi.nlm.nih.gov/17328886/
^ Regulates chondrocyte proliferation ^
https://pubmed.ncbi.nlm.nih.gov/10571683/
^ Maintains proliferative chondrocytes ^
https://pubmed.ncbi.nlm.nih.gov/25196529/

[SIZE=15px] ^ PTH1R supports long bone growth ^[/SIZE]
[SIZE=26px][B]LMK IF YALL WANT AN UPDATED POST WITH DOSING SOURCING AND SIDE EFFECTS/SIDE EFFECT MITIGATION[/B][/SIZE]
bruh it fucked up the format :(
 
NEW .ORG ACCOUNT I HAVE BEEN ON FORUMS FOR 7 YEARS
V (MY TIKTOK ACCOUNT) V
:love:WOULD LOVE A FOLLOW IF YOU LIKED THIS POST:love:

View attachment 5530125
ABALOPARATIDE
View attachment 5530171

Absorption:
Abaloparatide is injected and enters the bloodstream
Main pathway:
Activates PTH1R signaling which recruits more osteoblasts
existing osteoblasts STAY alive longer and activates previously inactive bone forming surfaces.


[U][I]PTH1R activation > [/I][/U]
[U][I]LOWER osteoblast apoptosis + INCREASED osteoblast recruitment > [/I][/U]
[U][I]INCREASED active mineralizing surfaces >[/I][/U]
INCREASED bone formation rate

Osteoblast effect:
PTH1R signaling increases osteoblast recruitment More osteoblasts become active and deposit osteoid increasing the amount of bone surface undergoing mineralization.
Bone matrix production:
Active osteoblasts deposit type-I collagen and other proteins forming new osteoid.
on the outside surface of cortical bone.
This is the actual material that increases outward bone volume.

Mineralization:
Calcium and phosphate are then deposited into that newly produced matrix converting the soft osteoid into hard mineralized cortical bone.
Chondrocyte effect:
Delayed maturation:
PTH1R signaling keeps those cells in the proliferative state longer and delays their transition into hypertrophic chondrocytes.
Maintained proliferative pool:
This preserves more immature chondrocytes that can continue dividing before they eventually mature.
12.9× increase:
increased periosteal mineralizing surface from 1.3% to 16.3% after 3 months a 12.9× increase in the amount of periosteal surface actively forming bone
studied osteoporotic population HARD
TO COMPARE % TO NON osteoporotic PEOPLE
https://pubmed.ncbi.nlm.nih.gov/33434314/

INCREASED final height and long bone length
(SOURCES)

t.https://pubmed.ncbi.nlm.nih.gov/26562265/
^ Abaloparatide activates PTH1R ^
https://pubmed.ncbi.nlm.nih.gov/17517365/
^ PTH increases osteoblast survival ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Activates bone forming surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases mineralizing surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases bone formation rate ^
https://pubmed.ncbi.nlm.nih.gov/39349089/
^ Chondrocytes drive bone lengthening ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases periosteal bone formation ^
https://pubmed.ncbi.nlm.nih.gov/31051317/
^ Increases periosteal mineralizing surface ^
https://pubmed.ncbi.nlm.nih.gov/16831900/
^ Delays chondrocyte differentiation ^
https://pubmed.ncbi.nlm.nih.gov/17328886/
^ Regulates chondrocyte proliferation ^
https://pubmed.ncbi.nlm.nih.gov/10571683/
^ Maintains proliferative chondrocytes ^
https://pubmed.ncbi.nlm.nih.gov/25196529/

[SIZE=15px] ^ PTH1R supports long bone growth ^[/SIZE]
[SIZE=26px][B]LMK IF YALL WANT AN UPDATED POST WITH DOSING SOURCING AND SIDE EFFECTS/SIDE EFFECT MITIGATION[/B][/SIZE]
b
 
NEW .ORG ACCOUNT I HAVE BEEN ON FORUMS FOR 7 YEARS
V (MY TIKTOK ACCOUNT) V
:love:WOULD LOVE A FOLLOW IF YOU LIKED THIS POST:love:

View attachment 5530125
ABALOPARATIDE
View attachment 5530171

Absorption:
Abaloparatide is injected and enters the bloodstream
Main pathway:
Activates PTH1R signaling which recruits more osteoblasts
existing osteoblasts STAY alive longer and activates previously inactive bone forming surfaces.


[U][I]PTH1R activation > [/I][/U]
[U][I]LOWER osteoblast apoptosis + INCREASED osteoblast recruitment > [/I][/U]
[U][I]INCREASED active mineralizing surfaces >[/I][/U]
INCREASED bone formation rate

Osteoblast effect:
PTH1R signaling increases osteoblast recruitment More osteoblasts become active and deposit osteoid increasing the amount of bone surface undergoing mineralization.
Bone matrix production:
Active osteoblasts deposit type-I collagen and other proteins forming new osteoid.
on the outside surface of cortical bone.
This is the actual material that increases outward bone volume.

Mineralization:
Calcium and phosphate are then deposited into that newly produced matrix converting the soft osteoid into hard mineralized cortical bone.
Chondrocyte effect:
Delayed maturation:
PTH1R signaling keeps those cells in the proliferative state longer and delays their transition into hypertrophic chondrocytes.
Maintained proliferative pool:
This preserves more immature chondrocytes that can continue dividing before they eventually mature.
12.9× increase:
increased periosteal mineralizing surface from 1.3% to 16.3% after 3 months a 12.9× increase in the amount of periosteal surface actively forming bone
studied osteoporotic population HARD
TO COMPARE % TO NON osteoporotic PEOPLE
https://pubmed.ncbi.nlm.nih.gov/33434314/

INCREASED final height and long bone length
(SOURCES)

t.https://pubmed.ncbi.nlm.nih.gov/26562265/
^ Abaloparatide activates PTH1R ^
https://pubmed.ncbi.nlm.nih.gov/17517365/
^ PTH increases osteoblast survival ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Activates bone forming surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases mineralizing surfaces ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases bone formation rate ^
https://pubmed.ncbi.nlm.nih.gov/39349089/
^ Chondrocytes drive bone lengthening ^
https://pubmed.ncbi.nlm.nih.gov/33434314/
^ Increases periosteal bone formation ^
https://pubmed.ncbi.nlm.nih.gov/31051317/
^ Increases periosteal mineralizing surface ^
https://pubmed.ncbi.nlm.nih.gov/16831900/
^ Delays chondrocyte differentiation ^
https://pubmed.ncbi.nlm.nih.gov/17328886/
^ Regulates chondrocyte proliferation ^
https://pubmed.ncbi.nlm.nih.gov/10571683/
^ Maintains proliferative chondrocytes ^
https://pubmed.ncbi.nlm.nih.gov/25196529/

[SIZE=15px] ^ PTH1R supports long bone growth ^[/SIZE]
[SIZE=26px][B]LMK IF YALL WANT AN UPDATED POST WITH DOSING SOURCING AND SIDE EFFECTS/SIDE EFFECT MITIGATION[/B][/SIZE]
Dnr but how much does it cost per year
 

Similar threads

mewannaascendnow
Replies
9
Views
88
sharkboa
sharkboa
jaran
Replies
28
Views
416
eka
eka
KiriB
Replies
4
Views
53
jotunnr
jotunnr
heightpill888
Replies
2
Views
34
foidsaremean
F
L1G7
Replies
3
Views
73
Thatsall101
Thatsall101

Users who are viewing this thread

Back
Top